MYCOPHENOLIC ACID INOVAMED 180 MG

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

MYCOPHENOLIC ACID

Disponible desde:

INOVAMED LTD

Código ATC:

L04AA06

formulario farmacéutico:

TABLETS DELAYED RELEASE

Composición:

MYCOPHENOLIC ACID 180 MG

Vía de administración:

PER OS

tipo de receta:

Required

Fabricado por:

BIOCON PHARMA LTD., INDIA

Área terapéutica:

MYCOPHENOLIC ACID

indicaciones terapéuticas:

Mycophenolic Inovamed is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.

Fecha de autorización:

2023-06-27

Información para el usuario

PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS )PREPARATIONS( – 1986
The medicine is dispensed with a doctor’s prescription only
Mycophenolic acid Inovamed 180 mg
Mycophenolic acid Inovamed 360 mg
Delayed-release tablets
Each delayed-release tablet contains:
Mycophenolic acid Inovamed 180 mg:
180 mg Mycophenolic acid )equivalent to 192.351 mg Mycophenolate
sodium(
Mycophenolic acid Inovamed 360 mg:
360 mg Mycophenolic acid )equivalent to 384.701 mg Mycophenolate
sodium(
For a list of inactive and allergenic ingredients in the preparation:
see section 6 “Further information” and
in section 2 “Important information about some of the ingredients of
the medicine”.
Read the leaflet carefully in its entirety before using the medicine.
This leaflet contains concise
information about the medicine. If you have further questions, refer
to the doctor or pharmacist.
This medicine has been prescribed to treat your ailment. Do not pass
it on to others. It may harm them
even if it seems to you that their ailment is similar.
Important information for your review
• Warning: Mycophenolate causes miscarriages and birth defects. If
you are a woman who is able to
conceive, you need to undergo a pregnancy test with a negative result
before starting treatment and
follow the contraception advice given to you by the attending doctor.
• Your doctor will discuss with you, in particular, the effects of
mycophenolate on unborn babies. Please
study the information thoroughly and follow the instructions.
• Before taking the preparation, consult a doctor again if you did
not fully understand the instructions.
For more information, see the section “Special warnings regarding
use of the medicine” and the section
“Pregnancy, breastfeeding and contraception”.
1. WHAT IS THE MEDICINE INTENDED FOR?
Mycophenolic acid Inovamed is given in combination with cyclosporine
and corticosteroids to prevent
graft rejection in adult kidney transplant recipients.
If you have any questions about how Mycophenolic